Hamid R Sadeghnia Selected Research

safranal

1/2021	Safranal protects against ischemia-induced PC12 cell injury through inhibiting oxidative stress and apoptosis.
1/2017	Neuroprotective effect of safranal, an active ingredient of Crocus sativus , in a rat model of transient cerebral ischemia.
1/2008	Antiabsence effects of safranal in acute experimental seizure models: EEG and autoradiography.
8/2005	Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hamid R Sadeghnia Research Topics

Disease

5	Ischemia 01/2021 - 08/2005
4	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2019
4	Brain Ischemia (Cerebral Ischemia) 01/2017 - 08/2005
4	Reperfusion Injury 01/2017 - 08/2005
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2016
3	Memory Disorders (Memory Loss) 01/2022 - 01/2018
3	Neuralgia (Stump Neuralgia) 10/2020 - 01/2020
2	Neuroinflammatory Diseases 01/2022 - 01/2020
2	Seizures (Absence Seizure) 01/2022 - 01/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2021 - 09/2020
2	Inflammation (Inflammations) 10/2020 - 01/2020
2	Multiple Sclerosis 06/2019 - 05/2017
2	Demyelinating Diseases (Demyelinating Disease) 06/2019 - 05/2017
2	Stroke (Strokes) 01/2017 - 12/2016
1	Tauopathies 01/2022
1	Hypersensitivity (Allergy) 10/2020
1	Necrosis 10/2020
1	Pain (Aches) 01/2020
1	Dementia (Dementias) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Cognitive Dysfunction 01/2019
1	Hyperuricemia 06/2018
1	Infarction (Infarctions) 01/2017
1	Transient Ischemic Attack 01/2017
1	Brain Injuries (Brain Injury) 01/2017
1	Brain Infarction 12/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2016
1	Spasm (Spasms) 05/2009
1	Body Weight (Weight, Body) 08/2005
1	Kidney Diseases (Kidney Disease) 08/2005

Drug/Important Bio-Agent (IBA)

4	safranalIBA 01/2021 - 08/2005
4	Thiobarbituric Acid Reactive SubstancesIBA 01/2017 - 08/2005
4	AntioxidantsIBA 01/2017 - 08/2005
3	Glutamic Acid (Glutamate)FDA Link 05/2021 - 06/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 08/2005
3	salicylhydroxamic acid (SHAM)IBA 09/2007 - 08/2005
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 01/2018
2	Sulfhydryl Compounds (Thiols)IBA 10/2020 - 08/2005
2	Malondialdehyde (Propanedial)IBA 10/2020 - 09/2007
2	TOR Serine-Threonine KinasesIBA 09/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2020
2	auraptenIBA 07/2019 - 01/2019
2	Free RadicalsIBA 06/2019 - 05/2017
2	Quinolinic AcidIBA 06/2019 - 05/2017
2	Superoxide DismutaseIBA 01/2019 - 12/2016
2	thymoquinoneIBA 01/2019 - 09/2007
2	Neuroprotective AgentsIBA 01/2017 - 12/2016
2	4-Butyrolactone (gamma Butyrolactone)IBA 05/2009 - 01/2008
2	Baclofen FDA LinkGeneric 05/2009 - 01/2008
1	CytokinesIBA 01/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2022
1	AcetylcholinesteraseIBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	galbanic acidIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	AcetoneIBA 10/2020
1	cedrolIBA 10/2020
1	PhytochemicalsIBA 09/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2020
1	Phosphotransferases (Kinase)IBA 09/2020
1	Protein Kinases (Protein Kinase)IBA 09/2020
1	Mitogen-Activated Protein KinasesIBA 09/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2020
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2020
1	beta CateninIBA 01/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019
1	EsterasesIBA 01/2019
1	potassium oxonateIBA 06/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	Everolimus FDA Link 01/2018
1	Tryptophan (L-Tryptophan)FDA Link 05/2017
1	Glutathione (Reduced Glutathione)IBA 12/2016
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	Nigella sativa oilIBA 12/2014
1	PicrotoxinIBA 01/2008
1	Pentylenetetrazole (Metrazol)IBA 01/2008
1	BicucullineIBA 01/2008
1	Phenytoin (Dilantin)FDA LinkGeneric 09/2007
1	thiobarbituric acidIBA 09/2007
1	crocinIBA 08/2005
1	Saline SolutionIBA 08/2005

Therapy/Procedure

2	Therapeutics 01/2020 - 08/2005
1	Catheters 12/2014
1	Warm Ischemia 08/2005